|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
JPS58501544A
(ja)
|
1981-09-08 |
1983-09-16 |
ザ ロツクフエラ− ユニヴア−シテイ |
エンドトキシン誘発メディエ−タ−（ショック検定）によるリポプロティンリパ−ゼの抑圧
|
|
US4510245A
(en)
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
DE3572982D1
(en)
|
1984-03-06 |
1989-10-19 |
Takeda Chemical Industries Ltd |
Chemically modified lymphokine and production thereof
|
|
US5672347A
(en)
*
|
1984-07-05 |
1997-09-30 |
Genentech, Inc. |
Tumor necrosis factor antagonists and their use
|
|
IL73883A
(en)
|
1984-12-20 |
1990-12-23 |
Yeda Res & Dev |
Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
EP0613006A1
(en)
|
1985-08-16 |
1994-08-31 |
The Rockefeller University |
Antibodies to cachectin and immunoassays
|
|
US4968615A
(en)
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
|
EP0230574A3
(en)
|
1986-01-31 |
1989-03-22 |
Yale University |
Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
|
|
DE3631229A1
(de)
|
1986-09-13 |
1988-03-24 |
Basf Ag |
Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung
|
|
NZ229922A
(en)
|
1988-07-18 |
1992-04-28 |
Chiron Corp |
Monoclonal antibodies specifically binding cachectin (tumor necrosis factor) and compositions
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
DE68914244T2
(de)
|
1988-10-24 |
1994-10-27 |
Otsuka Pharma Co Ltd |
Monoklonaler Antikörper.
|
|
ATE147634T1
(de)
|
1988-12-19 |
1997-02-15 |
American Cyanamid Co |
Produkte zur behandlung des endotoxin -schocks bei einem säugetier
|
|
WO1990006952A1
(fr)
|
1988-12-22 |
1990-06-28 |
Kirin-Amgen, Inc. |
Facteur de stimulation de colonies de granulocytes modifies chimiquement
|
|
CA2003981C
(en)
|
1988-12-27 |
2000-06-13 |
Hiroshi Ishimaru |
Pharmaceutical compositions and use thereof in the treatment of psoriasis
|
|
US6451983B2
(en)
|
1989-08-07 |
2002-09-17 |
Peptech Limited |
Tumor necrosis factor antibodies
|
|
JP3443119B2
(ja)
|
1989-08-07 |
2003-09-02 |
ペプテック リミテッド |
腫瘍壊死因子結合リガンド
|
|
US5959087A
(en)
*
|
1989-08-07 |
1999-09-28 |
Peptide Technology, Ltd. |
Tumour necrosis factor binding ligands
|
|
FR2651130B1
(fr)
|
1989-08-23 |
1991-12-13 |
Roussel Uclaf |
Sequence d'oligonucleotides anti-sens, anti-arn message du tnf alpha, procede de preparation, application a titre de medicaments et compositions pharmaceutiques.
|
|
WO1991003553A1
(en)
|
1989-09-05 |
1991-03-21 |
Immunex Corporation |
TUMOR NECROSIS FACTOR-α AND -β RECEPTORS
|
|
GB8921123D0
(en)
|
1989-09-19 |
1989-11-08 |
Millar Ann B |
Treatment of ards
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
US5859205A
(en)
*
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
DE4037604A1
(de)
|
1990-04-25 |
1991-10-31 |
Bayer Ag |
Verwendung von anti-tnf-antikoerpern als arzneimittel bei der behandlung von ischaemien und deren folgen
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9014932D0
(en)
*
|
1990-07-05 |
1990-08-22 |
Celltech Ltd |
Recombinant dna product and method
|
|
DK0585287T3
(da)
|
1990-07-10 |
2000-04-17 |
Cambridge Antibody Tech |
Fremgangsmåde til fremstilling af specifikke bindingsparelementer
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
CA2095633C
(en)
|
1990-12-03 |
2003-02-04 |
Lisa J. Garrard |
Enrichment method for variant proteins with altered binding properties
|
|
GB9109645D0
(en)
|
1991-05-03 |
1991-06-26 |
Celltech Ltd |
Recombinant antibodies
|
|
GB2279077B
(en)
|
1990-12-21 |
1995-06-14 |
Celltech Ltd |
Therapeutic compositions comprising recombinant antibodies specific for the TNFalpha
|
|
US5994510A
(en)
*
|
1990-12-21 |
1999-11-30 |
Celltech Therapeutics Limited |
Recombinant antibodies specific for TNFα
|
|
GB9028123D0
(en)
|
1990-12-28 |
1991-02-13 |
Erba Carlo Spa |
Monoclonal antibodies against human tumor necrosis factor alpha
|
|
EP1820858B1
(en)
|
1991-03-01 |
2009-08-12 |
Dyax Corporation |
Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof
|
|
ATE240740T1
(de)
|
1991-03-15 |
2003-06-15 |
Amgen Inc |
Pegylation von polypeptiden
|
|
EP1857553A1
(en)
|
1991-03-18 |
2007-11-21 |
New York University |
Monoclonal and chimeric antibodies specific for human tumor necrosis factor
|
|
US6277969B1
(en)
*
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
US7192584B2
(en)
*
|
1991-03-18 |
2007-03-20 |
Centocor, Inc. |
Methods of treating psoriasis with anti-TNF antibodies
|
|
US5656272A
(en)
*
|
1991-03-18 |
1997-08-12 |
New York University Medical Center |
Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies
|
|
US20070298040A1
(en)
*
|
1991-03-18 |
2007-12-27 |
Centocor, Inc. |
Methods of treating seronegative arthropathy with anti-TNF antibodies
|
|
US20060246073A1
(en)
*
|
1991-03-18 |
2006-11-02 |
Knight David M |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
US20040120952A1
(en)
*
|
2000-08-07 |
2004-06-24 |
Centocor, Inc |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
ES2123515T3
(es)
|
1991-03-29 |
1999-01-16 |
Immunex Corp |
Antagonistas de citoquinas a base de proteinas virales aisladas.
|
|
ATE414768T1
(de)
|
1991-04-10 |
2008-12-15 |
Scripps Research Inst |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
EP0605522B1
(en)
|
1991-09-23 |
1999-06-23 |
Medical Research Council |
Methods for the production of humanized antibodies
|
|
WO1993011793A1
(en)
|
1991-12-17 |
1993-06-24 |
Schering Corporation |
Use of the combination of anti-tumor necrosis factor plus interleukin-6 to treat septic shock
|
|
JP3251587B2
(ja)
|
1992-04-02 |
2002-01-28 |
スミスクライン・ビーチャム・コーポレイション |
炎症疾患の治療および腫瘍壊死因子の産生阻害に有用な化合物
|
|
ES2121907T3
(es)
|
1992-08-28 |
1998-12-16 |
Bayer Ag |
Uso de anticuerpos monoclonales anti-tnf para el tratamiento de meningitis bacterianas.
|
|
AU670125B2
(en)
|
1992-09-15 |
1996-07-04 |
Immunex Corporation |
Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
|
|
US6270766B1
(en)
|
1992-10-08 |
2001-08-07 |
The Kennedy Institute Of Rheumatology |
Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
|
|
EP0671936A1
(en)
|
1992-10-15 |
1995-09-20 |
Dana-Farber Cancer Institute, Inc. |
TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-$g(a) FUNCTION
|
|
US5888511A
(en)
*
|
1993-02-26 |
1999-03-30 |
Advanced Biotherapy Concepts, Inc. |
Treatment of autoimmune diseases, including AIDS
|
|
DE69427928T3
(de)
|
1993-03-05 |
2012-05-10 |
Bayer Healthcare Llc |
Humane monoklonale anti-TNF alpha Antikörper
|
|
ATE183513T1
(de)
|
1993-06-03 |
1999-09-15 |
Therapeutic Antibodies Inc |
Herstellung von antikörperfragmenten
|
|
EP0659766A1
(en)
|
1993-11-23 |
1995-06-28 |
Schering-Plough |
Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
|
|
NZ278607A
(en)
*
|
1994-02-07 |
1999-05-28 |
Knoll Ag |
Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above
|
|
JPH09509835A
(ja)
|
1994-03-04 |
1997-10-07 |
メルク エンド カンパニー インコーポレーテッド |
アラニン走査型突然変異誘発によるｉｎ ｖｉｔｒｏ抗体アフィニティー成熟
|
|
CN1153530A
(zh)
*
|
1995-03-09 |
1997-07-02 |
比奥美希奥公司 |
相关于类风湿性关节炎的msrv-1病毒和致病性和/或感染性msrv-2因子
|
|
AU2365795A
(en)
|
1995-04-20 |
1996-11-07 |
Centocor Inc. |
Multiple administrations of anti-tnf antibody
|
|
US6090382A
(en)
*
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
MX336813B
(es)
|
1996-02-09 |
2016-02-02 |
Abbvie Biotechnology Ltd |
Anticuerpos humanos que ligan el tnfa humano.
|
|
EP0816357B1
(en)
|
1996-06-27 |
2002-01-09 |
Pfizer Inc. |
Substituted indazole derivatives
|
|
JP2000516594A
(ja)
|
1996-07-26 |
2000-12-12 |
スミスクライン・ビーチャム・コーポレイション |
免疫細胞介在全身性疾患の改良された治療法
|
|
ES2200163T3
(es)
|
1996-11-15 |
2004-03-01 |
Darwin Discovery Limited |
Aril-carboxamidas biciclicas y su utilizacion terapeutica.
|
|
CN1178955C
(zh)
|
1997-04-15 |
2004-12-08 |
法默卡有限公司 |
经修饰的TNFα分子和编码该TNFα分子的DNA以及含有该TNFα分子和该DNA的疫苗
|
|
US20040009166A1
(en)
*
|
1997-04-30 |
2004-01-15 |
Filpula David R. |
Single chain antigen-binding polypeptides for polymer conjugation
|
|
EP0980258A1
(en)
|
1997-05-12 |
2000-02-23 |
The Kennedy Institute Of Rheumatology |
Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
|
|
DE19734293A1
(de)
*
|
1997-08-08 |
1999-02-11 |
Boehringer Mannheim Gmbh |
Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
|
|
JPH11127882A
(ja)
|
1997-10-27 |
1999-05-18 |
Nippon Kayaku Co Ltd |
新規生理活性物質ｎｋ３０４２４ａ，ｎｋ３０４２４ｂ，それらの製造法およびそれらの用途
|
|
US20030113318A1
(en)
|
1999-02-24 |
2003-06-19 |
Tobinick Edward Lewis |
TNF inhibition for the treatment of pre-menstrual syndrome and primary dysmenorrhea
|
|
US6419944B2
(en)
*
|
1999-02-24 |
2002-07-16 |
Edward L. Tobinick |
Cytokine antagonists for the treatment of localized disorders
|
|
US6423321B2
(en)
*
|
1999-02-24 |
2002-07-23 |
Edward L. Tobinick |
Cytokine antagonists for the treatment of sensorineural hearing loss
|
|
US6177077B1
(en)
|
1999-02-24 |
2001-01-23 |
Edward L. Tobinick |
TNT inhibitors for the treatment of neurological disorders
|
|
US6537549B2
(en)
|
1999-02-24 |
2003-03-25 |
Edward L. Tobinick |
Cytokine antagonists for the treatment of localized disorders
|
|
US6379666B1
(en)
*
|
1999-02-24 |
2002-04-30 |
Edward L. Tobinick |
TNF inhibitors for the treatment of neurological, retinal and muscular disorders
|
|
DE60003863T2
(de)
*
|
1999-03-31 |
2004-04-22 |
Pfizer Products Inc., Groton |
Dioxocyclopentylhydroxamsäure
|
|
US20010021380A1
(en)
*
|
1999-04-19 |
2001-09-13 |
Pluenneke John D. |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
|
EP1171148A2
(en)
|
1999-04-19 |
2002-01-16 |
Immunex Corporation |
Soluble tumor necrosis factor receptor treatment of medical desorders
|
|
WO2000067776A1
(en)
|
1999-05-11 |
2000-11-16 |
Ortho-Mcneil Pharmaceuticals, Inc. |
Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
|
|
JP2003503360A
(ja)
|
1999-06-24 |
2003-01-28 |
ファルマシア コーポレイション |
炎症性疾患の処置のための併用療法
|
|
AU6875900A
(en)
|
1999-09-08 |
2001-04-10 |
Chugai Seiyaku Kabushiki Kaisha |
Protein solution preparation and method of stabilizing the same
|
|
WO2001037874A2
(en)
|
1999-11-24 |
2001-05-31 |
Centocor, Inc. |
Treatment of psoriasis by using an antibody to tnf alpha
|
|
PT1237575E
(pt)
|
1999-12-14 |
2008-11-17 |
Genentech Inc |
Antagonista de tnf-alfa e antagonista de lfa-1 para tratar a artrite reumatóide
|
|
AR026801A1
(es)
|
2000-01-12 |
2003-02-26 |
Medidom Lab |
Sustancias para uso en el tratamiento de la psoriasis
|
|
JP4812921B2
(ja)
|
2000-04-14 |
2011-11-09 |
田辺三菱製薬株式会社 |
ベーチェット病治療剤
|
|
GB0013810D0
(en)
*
|
2000-06-06 |
2000-07-26 |
Celltech Chiroscience Ltd |
Biological products
|
|
US7879328B2
(en)
*
|
2000-06-16 |
2011-02-01 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US20060018907A1
(en)
*
|
2000-08-07 |
2006-01-26 |
Centocor, Inc. |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
UA81743C2
(uk)
*
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
|
US20050249735A1
(en)
*
|
2000-08-07 |
2005-11-10 |
Centocor, Inc. |
Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
KR20030074693A
(ko)
|
2000-12-28 |
2003-09-19 |
알투스 바이올로직스 인코포레이티드 |
전항체 및 이의 단편의 결정과 이의 제조 및 사용 방법
|
|
US20030012786A1
(en)
*
|
2001-05-25 |
2003-01-16 |
Teoh Leah S. |
Use of anti-TNF antibodies as drugs in treating septic disorders of anemic patients
|
|
CA2817619A1
(en)
|
2001-06-08 |
2002-12-08 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
|
AR035119A1
(es)
|
2001-08-16 |
2004-04-14 |
Lilly Co Eli |
Anticuerpos humanos antagonistas anti-htnfsf13b
|
|
RS51829B
(sr)
*
|
2001-08-23 |
2012-02-29 |
Genmab A/S. |
Ljudska antitela specifična za interleukin 15 (il-15)
|
|
EA200400548A1
(ru)
|
2001-10-15 |
2005-06-30 |
Чирон Корпорейшн |
Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)
|
|
US20030161828A1
(en)
*
|
2002-02-19 |
2003-08-28 |
Abbott Gmbh & Co. Kg |
Use of TNF antagonists as drugs for the treatment of patients with an inflammatory reaction and without suffering from total organ failure
|
|
US20040009172A1
(en)
*
|
2002-04-26 |
2004-01-15 |
Steven Fischkoff |
Use of anti-TNFalpha antibodies and another drug
|
|
US20030206898A1
(en)
*
|
2002-04-26 |
2003-11-06 |
Steven Fischkoff |
Use of anti-TNFalpha antibodies and another drug
|
|
US20090280065A1
(en)
|
2006-04-10 |
2009-11-12 |
Willian Mary K |
Uses and Compositions for Treatment of Psoriasis
|
|
WO2004009776A2
(en)
|
2002-07-19 |
2004-01-29 |
Abbott Biotechnology Ltd. |
TREATMENT OF TNFα RELATED DISORDERS
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
US20040038874A1
(en)
|
2002-08-22 |
2004-02-26 |
Osemwota Omoigui |
Method of treatment of persistent pain
|
|
US7026301B2
(en)
|
2002-10-17 |
2006-04-11 |
New York University |
Method of orally treating inflammatory skin conditions with prodrugs of 5-fluorouracil
|
|
MY150740A
(en)
|
2002-10-24 |
2014-02-28 |
Abbvie Biotechnology Ltd |
Low dose methods for treating disorders in which tnf? activity is detrimental
|
|
US7438907B2
(en)
*
|
2002-11-15 |
2008-10-21 |
Genmab A/S |
Human monoclonal antibodies against CD25
|
|
US7807389B2
(en)
*
|
2003-03-14 |
2010-10-05 |
University Of Rochester |
Methods and compositions related to joint inflammation diseases
|
|
US7285256B2
(en)
|
2003-04-04 |
2007-10-23 |
Newmont Usa Limited |
Precious metal recovery using thiocyanate lixiviant
|
|
EP1670501A2
(en)
|
2003-09-25 |
2006-06-21 |
ZymoGenetics, Inc. |
Methods of treating autoimmune diseases using il-21
|
|
TW201705980A
(zh)
|
2004-04-09 |
2017-02-16 |
艾伯維生物技術有限責任公司 |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
WO2006041970A2
(en)
|
2004-10-08 |
2006-04-20 |
Abbott Biotechnology Ltd. |
Treatment of respiratory syncytial virus (rsv) infection
|
|
NZ595225A
(en)
*
|
2005-05-16 |
2013-05-31 |
Abbott Biotech Ltd |
Use of tnf inhibitor for treatment of erosive polyarthritis
|
|
US20070041905A1
(en)
|
2005-08-19 |
2007-02-22 |
Hoffman Rebecca S |
Method of treating depression using a TNF-alpha antibody
|
|
CN103336129A
(zh)
*
|
2005-11-01 |
2013-10-02 |
阿布维生物技术有限公司 |
使用生物标志物诊断强直性脊柱炎的方法和组合物
|
|
CN102887955A
(zh)
|
2006-04-05 |
2013-01-23 |
艾博特生物技术有限公司 |
抗体纯化
|
|
US20080118496A1
(en)
*
|
2006-04-10 |
2008-05-22 |
Medich John R |
Uses and compositions for treatment of juvenile rheumatoid arthritis
|
|
US9399061B2
(en)
*
|
2006-04-10 |
2016-07-26 |
Abbvie Biotechnology Ltd |
Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis
|
|
WO2008063213A2
(en)
*
|
2006-04-10 |
2008-05-29 |
Abbott Biotechnology Ltd. |
Uses and compositions for treatment of psoriatic arthritis
|
|
US20090317399A1
(en)
|
2006-04-10 |
2009-12-24 |
Pollack Paul F |
Uses and compositions for treatment of CROHN'S disease
|
|
WO2007120626A2
(en)
*
|
2006-04-10 |
2007-10-25 |
Abbott Biotechnology Ltd. |
Uses and compositions for treatment of ankylosing spondylitis
|
|
US9605064B2
(en)
|
2006-04-10 |
2017-03-28 |
Abbvie Biotechnology Ltd |
Methods and compositions for treatment of skin disorders
|
|
US20080131374A1
(en)
|
2006-04-19 |
2008-06-05 |
Medich John R |
Uses and compositions for treatment of rheumatoid arthritis
|
|
US20080311043A1
(en)
|
2006-06-08 |
2008-12-18 |
Hoffman Rebecca S |
Uses and compositions for treatment of psoriatic arthritis
|
|
US20100021451A1
(en)
|
2006-06-08 |
2010-01-28 |
Wong Robert L |
Uses and compositions for treatment of ankylosing spondylitis
|
|
MX2008016335A
(es)
|
2006-06-30 |
2009-01-21 |
Abbott Biotech Ltd |
Dispositivo automatico de inyeccion.
|
|
WO2008031013A1
(en)
|
2006-09-08 |
2008-03-13 |
Gene Logic Inc. |
Method for treating inflammatory diseases of the digestive tract
|
|
AU2007294731B2
(en)
|
2006-09-13 |
2014-04-17 |
Abbvie Inc. |
Cell culture improvements
|
|
ES2442258T3
(es)
|
2006-10-27 |
2014-02-10 |
Abbvie Biotechnology Ltd |
Anticuerpos cristalinos anti-hTNF alfa
|
|
RU2476442C2
(ru)
|
2007-03-29 |
2013-02-27 |
Эббот Лэборетриз |
Кристаллические антитела против il-12 человека
|
|
WO2008150491A2
(en)
|
2007-05-31 |
2008-12-11 |
Abbott Laboratories |
BIOMARKERS PREDICTIVE OF THE RESPONSIVENESS TO TNFα INHIBITORS IN AUTOIMMUNE DISORDERS
|
|
EP2152318A4
(en)
|
2007-06-01 |
2011-12-07 |
Abbott Biotech Ltd |
COMPOSITIONS AND USES FOR THE TREATMENT OF PSORIASIS AND CROHN'S DISEASE
|
|
WO2008154543A2
(en)
*
|
2007-06-11 |
2008-12-18 |
Abbott Biotechnology Ltd. |
Methods for treating juvenile idiopathic arthritis
|
|
JP2010533181A
(ja)
*
|
2007-07-13 |
2010-10-21 |
アボツト・バイオテクノロジー・リミテツド |
ＴＮＦα阻害剤の肺投与のための方法及び組成物
|
|
WO2009020654A1
(en)
|
2007-08-08 |
2009-02-12 |
Abbott Laboratories |
Compositions and methods for crystallizing antibodies
|
|
US8969024B2
(en)
|
2007-08-28 |
2015-03-03 |
Abbvie Biotechnology Ltd |
Compositions and methods comprising binding proteins for adalimumab
|
|
US8420081B2
(en)
|
2007-11-30 |
2013-04-16 |
Abbvie, Inc. |
Antibody formulations and methods of making same
|
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
|
US20090271164A1
(en)
*
|
2008-01-03 |
2009-10-29 |
Peng Joanna Z |
Predicting long-term efficacy of a compound in the treatment of psoriasis
|
|
TWI478937B
(zh)
*
|
2008-01-15 |
2015-04-01 |
Abbvie Inc |
改良之哺乳動物表現載體及其用途
|
|
CA2711984A1
(en)
*
|
2008-01-15 |
2009-07-23 |
Abbott Gmbh & Co. Kg |
Powdered protein compositions and methods of making same
|
|
CN102065892A
(zh)
|
2008-01-30 |
2011-05-18 |
雅培制药有限公司 |
用于使抗体片段结晶的组合物和方法
|
|
JP2011517672A
(ja)
|
2008-03-24 |
2011-06-16 |
アボツト・バイオテクノロジー・リミテツド |
骨損失を治療するための方法及び組成物
|
|
WO2010127146A1
(en)
|
2009-04-29 |
2010-11-04 |
Abbott Biotechnology Ltd |
Automatic injection device
|
|
US20100278822A1
(en)
|
2009-05-04 |
2010-11-04 |
Abbott Biotechnology, Ltd. |
Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
|
|
JP2013518590A
(ja)
|
2010-02-02 |
2013-05-23 |
アボツト・バイオテクノロジー・リミテツド |
ＴＮＦ−α阻害剤を用いる処置に対する応答性を予測するための方法および組成物
|
|
EP2575884B1
(en)
|
2010-06-03 |
2018-07-18 |
AbbVie Biotechnology Ltd |
Uses and compositions for treatment of hidradenitis suppurativa (hs)
|
|
US8821865B2
(en)
|
2010-11-11 |
2014-09-02 |
Abbvie Biotechnology Ltd. |
High concentration anti-TNFα antibody liquid formulations
|